Skip to main content

Advertisement

SpringerLink
Log in

Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Genetic alterations in the deleted in colorectal carcinoma (DCC) gene have been a priori reported to associate with metastasis in variety of human cancers. We investigated the association between potentially functional SNPs in DCC and susceptibility to esophageal (EC) and gastric (GC) cancers in Kashmir Valley. We genotyped two SNPs DCC rs714 (A>G) and DCC rs2229080 (C>G) of DCC in 135 EC patients, 108 GC patients, and 195 controls matched by age and sex in Kashmir Valley by polymerase chain reaction–RFLP method. Risk for developing EC and GC was estimated by binary logistic regression by using SPSS. We also performed a meta-analysis on DCC rs714 (A>G) and evaluated the association between the DCC rs714 (A>G) polymorphisms and cancer risk. A significant difference in DCC rs714 (A>G) genotype distribution between EC and GC cases and corresponding control groups was observed (odds ratio (OR) = 1.92; P = 0.03; P-trend = 0.04; false discovery rate (FDR) Pcorr = 0.03: OR = 2.15; P = 0.02; P-trend = 0.01; FDR Pcorr = 0.03). But no such association was observed in DCC rs2229080 (C>G). Further, DCC rs714 (A>G) AA genotype showed significantly increased risk for both gastric squamous cell carcinoma (OR = 5.63; P = 0.02; FDR Pcorr = 0.01) and gastric adenocarcinoma (OR = 2.15; P = 0.02; FDR Pcorr = 0.01). Smoking and salted tea are independently associated with both EC and GC, but gene–environment interaction did not further modulate the risk. Meta-analysis also suggested both independent and overall association of DCC rs714 (A>G) polymorphism with cancer (P = 0.000). In conclusion, genetic variations in DCC rs714 (A>G) modulate risk of EC and GC in high-risk Kashmir population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594–606.

    Article  CAS  PubMed  Google Scholar 

  2. Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. 2008;13(2):102–11.

    Article  PubMed  Google Scholar 

  3. Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33:11–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, Preussmann R. Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis. 1992;13:1331–5.

    Article  CAS  PubMed  Google Scholar 

  5. Siddiqiz M, Tricker AR, Preussmann R. The occurrence of preformed N nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir India. Cancer Lett. 1988;39:37–43.

    Article  Google Scholar 

  6. Malik MA, Zargar SA, Mittal B. Role of NQO1 609C>T and NQO2–3423G>A gene polymorphisms in esophageal cancer risk in Kashmir Valley and meta analysis. Mol Biol Rep. 2012;39(9):9095–104.

    Article  CAS  PubMed  Google Scholar 

  7. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer. 2009;40:26–32.

    Article  CAS  PubMed  Google Scholar 

  8. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, et al. The DCC gene: structural analysis and mutations in colorectal carcinomas. Vogelstein B Genomics. 1994;19(3):525–31.

    Article  CAS  PubMed  Google Scholar 

  9. Krimpenfort P, Song JY, Proost N, Zevenhoven J, Jonkers J, Berns A. Deleted in Colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours. Nature. 2012;482(7386):538–41. doi:10.1038/nature10790.

    Article  CAS  PubMed  Google Scholar 

  10. Maran S. Lee YY, Xu S, Rajab NS, Hasan N, Mustaffa N et al. Deleted in Colorectal Cancer (DCC) Gene Polymorphism is associated with H. pylori infection among susceptible Malays from the North-Eastern Region of Peninsular Malaysia. Hepatogastroenterology. 2012;Jul 25;60(121). doi: 10.5754/hge12471.

  11. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990;247:49–56.

    Article  CAS  PubMed  Google Scholar 

  12. Fearon ER, Vogelste B. A genetic mode l for colorectal tumorigenesis. Cell. 1990;61:759–67.

    Article  CAS  PubMed  Google Scholar 

  13. Itoh F, Hinoda Y, Ohe M, Ohe Y, Ban T, Endo T, et al. Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer. 1993;53:260–3.

    Article  CAS  PubMed  Google Scholar 

  14. Reale MA, Hu G, Zafar AI, Getzenberg RH, Levine SM, Fearon ER. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res. 1994;54:4493–501.

    CAS  PubMed  Google Scholar 

  15. Fearon ER. DCC: is there a connection between tumorigenesis and cell guidance molecules? Biochim Biophys Acta. 1996;9(1288):M17–23.

    Google Scholar 

  16. Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele Jr G, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med. 1996;335(23):1727–32.

    Article  CAS  PubMed  Google Scholar 

  17. Sun XF, Rütten S, Zhang H, Nordenskjöld B. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma. J Clin Oncol. 1999;17:1745–50.

    CAS  PubMed  Google Scholar 

  18. Toma M, Stavarachi M, Cimponeriu D, Apostol P, Cojocaru M, Belusica L et al. P53 And DCC Polymorphisms and the risk for colorectal cancer in Romanian patients—a preliminary study. Tom. XVI / 2, 2009, pp. 162–165.

  19. Cha PC, Zembutsu H, Takahashi A, Kubo M, Kamatani N, Nakamura YJ. A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population. Hum Genet. 2012;57(4):235–7. doi:10.1038/jhg.2012.9.

    Article  CAS  Google Scholar 

  20. Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B. DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: GENE-D-12-01446). Gene. 2013;2013 Jan 23.

  21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Carlson JM, Heckerman D, Shani G. Estimating false discovery rates for contingency tables. Microsoft research technical report. 2009 MSR-TR-2009-53.http://research.microsoft.com/en-us/um/redmond/projects/MSCompBio/ FalseDiscovery Rate/

  23. Comprehensive meta-analysis version 2.0. http://www.meta-analysis.com/

  24. Mattar R, Nonogaki S, Silva C, Alves V, Gama-Rodrigues JJ. P53 and Rb tumor suppressor gene alterations in gastric cancer. Rev Hosp Clin Fac Med Sao Paulo. 2004;59(4):172–80.

    Article  PubMed  Google Scholar 

  25. Schmitt CA, Thaler KR, Wittig BM, Kaulen H, Büschenfelde CKMZ, Dippold WG. Detection of the DCC gene product in normal and malignant colorectal tissues and its related to a codon 201 mutation. Br J Cancer. 1998;77:588–94.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992;52:3099–102.

    CAS  PubMed  Google Scholar 

  27. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res. 1992;52(23):6525–30.

    CAS  PubMed  Google Scholar 

  28. Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ. Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene. 1991;6(2):311–5.

    CAS  PubMed  Google Scholar 

  29. Gao X, Honn KV, Grignon D, Sakr W, Chen YQ. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993;53(12):2723–7.

    CAS  PubMed  Google Scholar 

  30. Höhne MW, Halatsch ME, Kahl GF, Weinel RJ. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 1992;52(9):2616–9.

    PubMed  Google Scholar 

  31. Scheck AC, Coons SW. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res. 1993;53:5605–9.

    CAS  PubMed  Google Scholar 

  32. Fang DC, Jass JR, Wang DX. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J Clin Pathol. 1998;51:593–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Cho JH, Noguchi M, Ochiai A, Hirohashi S. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Lab Invest. 1996;74:835–41.

    CAS  PubMed  Google Scholar 

  34. Candusso ME, Luinetti O, Villani L, Alberizzi P, Klersy C, Fiocca R, et al. Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol. 2002;197:44–50.

    Article  CAS  PubMed  Google Scholar 

  35. Yoshiya G, Takahata T, Hanada N, Suzuki K, Ishiguro A, Saito M, et al. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol. 2008;23:948–53.

    Article  CAS  PubMed  Google Scholar 

  36. Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, Gespach C, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature. 2004;431:80–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by a research grant from Indian Council of Medical Research New Delhi.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014, India

    Manzoor Ahmad Malik, Annapurna Gupta & Balraj Mittal

  2. Department of Gastroenterology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, 190011, India

    Showkat Ali Zargar

Authors
  1. Manzoor Ahmad Malik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annapurna Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Showkat Ali Zargar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Balraj Mittal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Balraj Mittal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malik, M.A., Gupta, A., Zargar, S.A. et al. Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis. Tumor Biol. 34, 3049–3057 (2013). https://doi.org/10.1007/s13277-013-0870-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0870-4

Keywords

Search

Navigation